Product Information
BUDESONIDE 32 MCG NASAL SPRAY is a generic product labeled by Apotex Corp., priced at $1.4117 per ML under NDC 60505612902. Its NADAC has been published 533 times since Jul 20, 2016.
FDA first approved this application on Nov 20, 2015.
Strength
32 ug/1
Manufacturer
Apotex Corp.NDC
60505612902
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078949FDA Approved
11/20/2015
On Market Since
4/19/2016
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 32 MCG NASAL SPRAY has been published 533 times since Jul 20, 2016, and over the history we have for it it has declined 11.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4117 per ML |
|---|---|
| All-time high | $1.9022 (Apr 13, 2022) |
| All-time low | $1.1947 (Apr 17, 2024) |
| 52-week high | $1.4255 |
| 52-week low | $1.3497 |
| Median price | $1.6070 |
| Average price | $1.5896 |
| Largest weekly change | +47.9% (Aug 21, 2024) |
| Weeks tracked | 533 |
| Tracking since | Jul 20, 2016 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Apotex Corp. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 32 MCG NASAL SPRAY?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 32 MCG NASAL SPRAY, manufactured by Apotex Corp., is $1.4117 per ML (NDC 60505612902), effective Sep 30, 2026.
How has the price of BUDESONIDE 32 MCG NASAL SPRAY changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 32 MCG NASAL SPRAY has declined 11.4%. It has been tracked across 533 weekly CMS publications since Jul 20, 2016.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 32 MCG NASAL SPRAY?
Since Jul 20, 2016, the NADAC for BUDESONIDE 32 MCG NASAL SPRAY has ranged from a low of $1.1947 (Apr 17, 2024) to a high of $1.9022 (Apr 13, 2022), with a median of $1.6070 per ML.
Are there cheaper alternatives to BUDESONIDE 32 MCG NASAL SPRAY?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE 32 MCG NASAL SPRAY, is $1.3880 per ML — about 2% below BUDESONIDE 32 MCG NASAL SPRAY.
Who manufactures BUDESONIDE 32 MCG NASAL SPRAY?
BUDESONIDE 32 MCG NASAL SPRAY (NDC 60505612902) is labeled by Apotex Corp., and CMS classifies it as a generic product.